CLINICAL_TRIALS
trial_result
· 2013-04-04
Clinical Trial Update: Bexarotene and Interferon Alfa in Treating Patients With Cutaneous T-Cell Lymphoma [Phase 2]
Summary
A Phase 2 trial evaluating the combination of bexarotene and interferon alfa for cutaneous T-cell lymphoma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Lymphoma | Phase 2 | Status: COMPLETED